Development and validation of a high-throughput qPCR platform for the detection of soil-transmitted helminth infections
Pilotte, Nils Omballa, Victor Voss, Monica Padgett, Leah Manuel, Malathi Goodman, Jeanne L Littlewood, Tim Manoharan, Zayina Zondervenni Lieshout, Lisette van Verweij, Jaco J
Pilotte, Nils
Omballa, Victor
Voss, Monica
Padgett, Leah
Manuel, Malathi
Goodman, Jeanne L
Littlewood, Tim
Manoharan, Zayina Zondervenni
Lieshout, Lisette van
Verweij, Jaco J
Citations
Altmetric:
Advisors
Editors
Other Contributors
Affiliation
EPub Date
Issue Date
2025-01
Submitted Date
Subject Terms
Collections
Research Projects
Organizational Units
Journal Issue
Other Titles
Abstract
<jats:sec id="sec001">
<jats:title>Background</jats:title>
<jats:p>Historically, soil-transmitted helminth (STH) control and prevention strategies have relied on mass drug administration efforts targeting preschool and school-aged children. While these efforts have succeeded in reducing morbidity associated with STH infection, recent modeling efforts have suggested that expanding intervention to treatment of the entire community could achieve transmission interruption in some settings. Testing the feasibility of such an approach requires large-scale clinical trials, such as the DeWorm3 cluster randomized trial. In addition, accurate interpretation of trial outcomes requires diagnostic platforms capable of accurately determining infection prevalence (particularly as infection intensity is reduced) at large population scale and with significant throughput. Here, we describe the development and validation of such a high-throughput molecular testing platform.</jats:p>
</jats:sec>
<jats:sec id="sec002">
<jats:title>Methodology/principal findings</jats:title>
<jats:p>Through the development, selection, and validation of appropriate controls, we have successfully created and evaluated the performance of a testing platform capable of the semi-automated, high-throughput detection of four species of STH in human stool samples. Comparison of this platform with singleplex reference assays for the detection of these same pathogens has demonstrated comparable performance metrics, with index assay accuracy measuring at or above 99.5% and 98.1% for each target species at the level of the technical replicate and individual extraction respectively. Through the implementation of a rigorous validation program, we have developed a diagnostic platform capable of providing the necessary throughput and performance required to meet the needs of the DeWorm3 cluster randomized trial and other large-scale operational research efforts for STH.</jats:p>
</jats:sec>
<jats:sec id="sec003">
<jats:title>Conclusions/significance</jats:title>
<jats:p>Resulting from the rigorous developmental approach taken, the platform we describe here provides the needed confidence in testing outcomes when utilized in conjunction with large-scale efforts such as the DeWorm3 trial. Additionally, the successful development of an evaluation and validation strategy provides a template for the creation of similar diagnostic platforms for other neglected tropical diseases.</jats:p>
</jats:sec>
Citation
Publisher
Journal
Research Unit
PubMed ID
PubMed Central ID
Embedded videos
Type
Journal Article
Item Description
Series/Report no.
ISSN
1935-2727
EISSN
1935-2735